Filing Details
- Accession Number:
- 0001179110-11-012413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-18 20:00:50
- Reporting Period:
- 2011-08-18
- Filing Date:
- 2011-08-18
- Accepted Time:
- 2011-08-18 20:00:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1477384 | A John Orwin | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-08-18 | 12,000 | $4.55 | 148,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- In connection with the grant of 60,000 shares of performance-based restricted stock units on September 22, 2010, 30,000 shares vested upon acceptance by the FDA of the NDA for peginesatide of which 12,000 shares were sold on August 18, 2011 pursuant to a 10b-5-1 plan in order to satisfy the tax withholding obligations that arose as a consequence of the vesting and delivery of the RSUs.
Billionaire Hedge Funds
